mTOR inhibition in mouse AD model ameliorated spheroid pathology.

Animal_Model Score: 0.500 Price: $0.50 Alzheimer's disease in_vivo Status: extracted

What This Experiment Tests

Animal_Model experiment designed to assess clinical efficacy targeting MTOR in in_vivo. Primary outcome: mTOR inhibition in mouse AD model ameliorated spheroid pathology.

Description

pharmacological mTOR inhibition in mouse model

TARGET GENE
MODEL SYSTEM
in_vivo
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
PI3K/AKT/mTOR
SOURCE
pmid_40065072
PRIMARY OUTCOME
mTOR inhibition in mouse AD model ameliorated spheroid pathology.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (4)

TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease0.827
APOE-Dependent Autophagy Restoration0.877
Chronic mTORC1-ULK1 signaling blocks autophagy initiation in irradiated pericytes0.578
Metabolic Checkpoint Reprogramming via TREM2-mTOR Axis0.455

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.